• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Pharma industry news

bavituximab

Peregrine Pharmaceuticals announces promising Bavituximab Phase I Data

Posted on: 1 April 2015 | Source: Victoria White

Peregrine has announced promising clinical data from a Phase I trial evaluating bavituximab therapy in patients with metastatic breast cancer...

paliperidone palmitate

New study finds three-month paliperidone palmitate significantly delayed time to relapse in patients with schizophrenia

Posted on: 1 April 2015 | Source: Victoria White

Three-month paliperidone palmitate significantly delayed time to relapse compared to placebo in patients with schizophrenia, according to a Phase 3 study...

KPI-121

Kala Pharmaceuticals announces positive results from Phase 3 trial of KPI-121 in cataract surgery

Posted on: 1 April 2015 | Source: Victoria White

Kala has announced positive results from a Phase 3 clinical trial of KPI-121 for the treatment of patients who have undergone cataract surgery...

invivo

InVivo Therapeutics announces new clinical trial site for Neuro-Spinal Scaffold

Posted on: 1 April 2015 | Source: Victoria White

InVivo has announced a new clinical site in the ongoing IDE pilot study of its Neuro-Spinal Scaffold in patients with acute spinal cord injury...

modhep

MODHEP film debuts at European Parliament

Posted on: 1 April 2015 | Source: Victoria White

"MODHEP: Understanding liver cancer" shown at European Parliament to delegates at an event celebrating collaboration between the EU and other countries...

Rheumatoid Arthritis

US Rheumatoid Arthritis treatment market value to reach $9.3 billion by 2020, says GBI Research

Posted on: 1 April 2015 | Source: Victoria White

The US treatment market for Rheumatoid Arthritis is set to increase in value from $6.4 billion in 2013 to $9.3 billion by 2020, says GBI Research...

ND0612L parkinson

NeuroDerm to announce updated topline results of Phase II Study of ND0612L for the treatment of Parkinson’s disease

Posted on: 1 April 2015 | Source: Victoria White

NeuroDerm has announced that updated results from the Phase II Study of ND0612L will be presented at the American Academy of Neurology 67th Annual Meeting...

bcx4430

BioCryst awarded advanced development funding for BCX4430 to treat Ebola and other filoviruses

Posted on: 1 April 2015 | Source: Victoria White

BioCryst has announced it has been has awarded a contract for the continued development of BCX4430 as a potential treatment for diseases, including Ebola...

ucb

UCB to focus on core business in India

Posted on: 1 April 2015 | Source: Victoria White

UCB has announced it has entered an agreement with Dr. Reddy’s to sell its established brands in India, allowing it to focus on its neurology portfolio...

entinostat

Syndax and Merck to collaborate on immuno-oncology study evaluating entinostat in combination with Keytruda in lung cancer and melanoma

Posted on: 31 March 2015 | Source: Victoria White

Syndax and Merck have entered into a clinical trial collaboration to evaluate the safety and efficacy of combining entinostat with Keytruda (pembrolizumab)...

nhs constitution

Boost for children’s understanding of healthcare rights and the NHS Constitution

Posted on: 31 March 2015 | Source: Victoria White

National Children's Bureau and Council for Disabled Children have published information to improve children's understanding of the NHS Constitution...

vienna

New post-hoc analyses extend understanding of the efficacy and safety of lurasidone in the treatment of schizophrenia

Posted on: 31 March 2015 | Source: Victoria White

Takeda and Sunovion today announced the results from 3 post-hoc analyses evaluating the efficacy and safety of lurasidone in patients with schizophrenia...